Age Ayurveda Nighantu

Punarnava

Boerhaavia diffusa

Punarnava (Boerhaavia diffusa) is a plant used in Ayurveda. Listed in the Ayurvedic Pharmacopoeia of India (API) as a rasayana (rejuvenative) category herb. Anti-inflammatory: Punarnavine inhibits pro-inflammatory cytokines IL-1alpha, IL-6, TNF-alpha, and GM-CSF while increasing IL-2 and IFN-gamma production.

Key facts
Botanical nameBoerhaavia diffusa
Identity sourceAyurvedic Pharmacopoeia of India, Part I, Vol. I: PUNARNAVA (RAKTA) (Whole plant)
Also calledBoerhaavia verticillata Poir. (attribution recorded without a cited source)
Trianthema portulacastrum Linn. (attribution recorded without a cited source)
Trianthema decandra L. (attribution recorded without a cited source)
FamilyNyctaginaceae
OrderCaryophyllales
Pharmacopoeia statusListed in the Ayurvedic Pharmacopoeia of India (API) as a rasayana (rejuvenative) category herb. Over 35 Ayurvedic formulations contain Punarnava as a major ingredient. Used across Ayurveda, traditional African, and South American medicine systems. Recognized in Indian Homoeopathic Pharmacopoeia as well. No standalone WHO monograph identified, but referenced in WHO traditional medicine literature for hepatoprotective and diuretic uses.
Taxon identifiersGBIF 7469489 · Wikidata Q115790884 · NCBI Taxonomy 930814

Names and identification

LanguageName
EnglishPunarnava

How does it work?

  • Anti-inflammatory: Punarnavine inhibits pro-inflammatory cytokines IL-1alpha, IL-6, TNF-alpha, and GM-CSF while increasing IL-2 and IFN-gamma production.
  • Anti-inflammatory: Extract inhibits Src/Syk/TRAF6 signaling pathway, suppressing NO and TNF-alpha production with decreased iNOS and TNF-alpha mRNA expression.
  • Diuretic: Saponins stimulate mild diuresis via increased glomerular filtration rate. Boeravinones enhance urine output without significant sodium loss.
  • Renal protection: Punarnavine and flavonoids curb inflammatory cascades in renal glomeruli, working synergistically with boeravinones.
  • Anti-obesity: Phytoconstituents block cannabinoid receptors (CB1), reducing HFD-induced weight gain and improving lipid profile.
  • Hepatoprotective: Boeravinones A and B protect hepatocytes against ethanol-induced toxicity via antioxidant mechanisms.
  • Immunomodulatory: Syringaresinol mono-beta-D-glucoside, punarnavine, and quercetin exhibit immunostimulant activity.
  • Anti-angiogenic: Punarnavine downregulates VEGF expression both in vitro and in vivo.
  • Key active constituents: Boeravinones A-G, punarnavine, rotenoids, flavonoids, quercetin, and syringaresinol mono-beta-D-glucoside.

What do recent clinical trials show?

3 further claims previously listed here could not be traced to a published paper and have been removed. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

  • Generally considered safe for short-term use in most healthy adults based on traditional use history, but comprehensive human safety data are lacking.
  • Diuretic effect may disrupt electrolyte balance, especially potassium levels, potentially affecting cardiac and muscular function.
  • May interact with diuretic medications (additive effect on fluid and electrolyte loss).
  • May interact with blood thinners (anticoagulants) — caution advised.
  • May interact with diabetes medications (potential additive hypoglycemic effect).
  • May interact with blood pressure medications (additive hypotensive effect).
  • Use with caution in patients with kidney disorders due to diuretic properties.
  • Gastrointestinal side effects possible: upset stomach, nausea, loose stools.
  • Avoid or use with medical supervision during pregnancy, breastfeeding, or concurrent use with allopathic medications.
  • Allergic reactions reported but uncommon.

Dosage forms and preparation

Dosage Forms: Churna (root/whole herb powder), Kwatha (decoction), Capsule, Tablet, Mandoora combination (Punarnavadi Mandoora), Swarasa (fresh juice), Guggulu combination, Asava

Standard Dosage: 3-6 g root powder daily; 20-40 mL decoction twice daily; 500 mg - 1 g standardized extract twice daily; 10-20 mL fresh juice daily

Bioavailability: Punarnavine (alkaloid) from Boerhavia diffusa has moderate oral bioavailability (30-45%). Boeravinone (rotenoid) shows variable absorption (15-30%) improved by lipid co-administration. Liriodendrin has moderate bioavailability (~25-35%). Ursolic acid requires lipid-based delivery for adequate absorption. Traditional decoction (Kwatha) may enhance bioavailability of polar constituents through solubilization.

Optimal Timing: Morning on empty stomach for diuretic effect (ensure adequate water intake). With meals for hepatoprotective use. Kwatha: morning and evening between meals.

Standardized Extract: Punarnava root extract (8:1) standardized to punarnavine >0.5%, boeravinone B >0.3%, total alkaloids >1.5%. Aqueous extract with ursolic acid >1% and validated HPTLC fingerprint.

Shelf Life: Dried root: 18-24 months; Churna: 18-24 months; Extract: 24-36 months; Capsules: 24-36 months; Asava: 5-10 years

Storage: Dried root and powder: airtight, below 25 deg C, RH <55%, protected from moisture and pest infestation. Extracts: amber containers, cool and dry. Fresh juice: refrigerated, use within 24 hours. Asava: amber glass, room temperature, improves with age.

Marker Compounds: Punarnavine, Boeravinone B, Boeravinone E, Liriodendrin, Ursolic acid, Beta-sitosterol, Hypoxanthine-9-L-arabinofuranoside, Eupalitin

Extraction Methods

  • Aqueous decoction (traditional Kwatha)
  • Hydroalcoholic extraction (50-60% ethanol)
  • Fresh root juice expression (Swarasa)
  • Methanol extraction for rotenoid profiling
  • Spray drying of aqueous extract
  • Traditional Asava preparation (fermented)

Synergistic Combinations

  • Gokshura (diuretic and renal health combination - Punarnavadi Guggulu|Punarnavadi Guggulu)
  • Mandoora Bhasma (iron + Punarnava for edema and anemia)
  • Guduchi (hepatoprotective and immunomodulatory)
  • Varuna (urinary tract and renal health)
  • Amalaki (rejuvenation and antioxidant synergy)
  • Shilajit (renal tonic combination)

Published research

Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.

Laboratory and animal studies1

  1. Khalid M, Alqarni MH, Shoaib A and others. 2022. Anti-Obesity Action of Boerhavia diffusa in Rats against High-Fat Diet-Induced Obesity by Blocking the Cannabinoid ReceptorsPlants (Basel, Switzerland). PMID 35567159 · doi:10.3390/plants11091158

Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.

Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.